Accelr8 Technology Corporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Accelr8 Technology Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Accelr8 Technology Corporation. The Company's principal activity is to develop and commercialize innovative, integrated system for rapid identification of bacteria and their antibiotic resistance in critically ill patients. The major products include BACcelr8r(tm), OptiChem(r), OptArray(TM). BACcelr8r(tm) intended to be used in clinical diagnostics for life-threatening bacterial infections. OptiChem(r) is into surface coatings and assay processing methods. OptArray(TM) produces micro arraying slides and also develops OptiPlate(TM) arrayable microtiter plates. The Company is granted license to Schott Jenaer Glas GmbH (SCHOTT), for manufacturing and marketing OptiChem microarraying products. The major trade marks include BACcelr8r, OptArray(TM),OptiChem(R), OptiPlate(TM),QuanDx(TM),YoDx(TM) and Quantum Microbiology(TM). The Company's office and laboratory is situated in Colorado.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report